Influence of diagnostic method on outcomes in phase 3 clinical trials of bezlotoxumab for the prevention of recurrent clostridioides difficile infection: A post Hoc analysis of MODIFY I/II

Mark H. Wilcox, Galia Rahav, Erik R. Dubberke, Lori Gabryelski, Kerrie Davies, Claire Berry, Karen Eves, Misoo C. Ellison, Dalya Guris, Mary Beth Dorr

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Influence of diagnostic method on outcomes in phase 3 clinical trials of bezlotoxumab for the prevention of recurrent clostridioides difficile infection: A post Hoc analysis of MODIFY I/II'. Together they form a unique fingerprint.

Medicine & Life Sciences